Gilead Sciences (XTER:GIS) Accumulated Depreciation : €-2,351 Mil (As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Gilead Sciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Gilead Sciences's quarterly accumulated depreciation increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€-2,359 Mil) but then stayed the same from Dec. 2024 (€-2,359 Mil) to Mar. 2025 (€-2,351 Mil).

Gilead Sciences's annual accumulated depreciation increased from Dec. 2022 (€-2,064 Mil) to Dec. 2023 (€-2,246 Mil) and increased from Dec. 2023 (€-2,246 Mil) to Dec. 2024 (€-2,359 Mil).

Gilead Sciences Accumulated Depreciation Historical Data

The historical data trend for Gilead Sciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Accumulated Depreciation Chart

Gilead Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-1,371.10

-1,675.31

-2,063.58

-2,245.73

-2,358.85

Gilead Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-2,358.85	-2,351.35

Gilead Sciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Gilead Sciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (XTER:GIS) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico 1GILD:Italy GISd:UK 0QYQ:UK GILD34:Brazil GILD:Austria GILD:Argentina

Address

333 Lakeside Drive, Foster City, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).